{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:27:38Z","timestamp":1786998458382,"version":"build-2736575974"},"reference-count":61,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T00:00:00Z","timestamp":1643846400000},"content-version":"vor","delay-in-days":367,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA189623"],"award-info":[{"award-number":["CA189623"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.ymthe.2020.10.016","type":"journal-article","created":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T01:25:35Z","timestamp":1603157135000},"page":"775-787","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Combinatorial Approaches to Enhance DNA Damage following Enzyme-Mediated Depletion of L-Cys for Treatment of Pancreatic Cancer"],"prefix":"10.1016","volume":"29","author":[{"given":"Achinto","family":"Saha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengyuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Georgiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Everett","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawit","family":"Kidane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"DiGiovanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2020.10.016_bib1","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ymthe.2020.10.016_bib2","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ymthe.2020.10.016_bib3","series-title":"SEER Cancer Statistics Review, 1975\u20132017","year":"2020"},{"key":"10.1016\/j.ymthe.2020.10.016_bib4","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.pan.2014.10.001","article-title":"Addressing the challenges of pancreatic cancer: future directions for improving outcomes","volume":"15","author":"Hidalgo","year":"2015","journal-title":"Pancreatology"},{"key":"10.1016\/j.ymthe.2020.10.016_bib5","first-page":"318","article-title":"Recent progress in pancreatic cancer","volume":"63","author":"Wolfgang","year":"2013","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ymthe.2020.10.016_bib6","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMra1404198","article-title":"Pancreatic adenocarcinoma","volume":"371","author":"Ryan","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2020.10.016_bib7","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41575-018-0005-x","article-title":"Therapeutic developments in pancreatic cancer: current and future perspectives","volume":"15","author":"Neoptolemos","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ymthe.2020.10.016_bib8","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","article-title":"Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine","volume":"369","author":"Von Hoff","year":"2013","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2020.10.016_bib9","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1158\/2159-8290.CD-11-0242","article-title":"nab-Paclitaxel potentiates gemcitabine activity by reducing cytidine deaminase levels in a mouse model of pancreatic cancer","volume":"2","author":"Frese","year":"2012","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ymthe.2020.10.016_bib10","doi-asserted-by":"crossref","first-page":"16022","DOI":"10.1038\/nrdp.2016.22","article-title":"Pancreatic cancer","volume":"2","author":"Kleeff","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ymthe.2020.10.016_bib11","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1056\/NEJMoa1809775","article-title":"FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer","volume":"379","author":"Conroy","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2020.10.016_bib12","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1001\/jamaoncol.2018.0329","article-title":"Total Neoadjuvant Therapy With FOLFIRINOX Followed by Individualized Chemoradiotherapy for Borderline Resectable Pancreatic Adenocarcinoma: A Phase 2 Clinical Trial","volume":"4","author":"Murphy","year":"2018","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.ymthe.2020.10.016_bib13","first-page":"1731","article-title":"Tumor-suppressive pathways in pancreatic carcinoma","volume":"57","author":"Rozenblum","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2020.10.016_bib14","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41575-019-0245-4","article-title":"Role of oncogenic KRAS in the diagnosis, prognosis and treatment of pancreatic cancer","volume":"17","author":"Buscail","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ymthe.2020.10.016_bib15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejca.2015.11.012","article-title":"Targeting KRAS for diagnosis, prognosis, and treatment of pancreatic cancer: Hopes and realities","volume":"54","author":"Bournet","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ymthe.2020.10.016_bib16","doi-asserted-by":"crossref","first-page":"8788","DOI":"10.1073\/pnas.1003428107","article-title":"Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity","volume":"107","author":"Weinberg","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2020.10.016_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jcp.10119","article-title":"Cellular response to oxidative stress: signaling for suicide and survival","volume":"192","author":"Martindale","year":"2002","journal-title":"J.\u00a0Cell. Physiol."},{"key":"10.1016\/j.ymthe.2020.10.016_bib18","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/jb\/mvr104","article-title":"Regulation of protein tyrosine phosphatases by reversible oxidation","volume":"150","author":"Ostman","year":"2011","journal-title":"J.\u00a0Biochem."},{"key":"10.1016\/j.ymthe.2020.10.016_bib19","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.molmed.2017.03.004","article-title":"ROS in Cancer: The Burning Question","volume":"23","author":"Chio","year":"2017","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ymthe.2020.10.016_bib20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/2049-3002-2-17","article-title":"Mitochondrial reactive oxygen species and cancer","volume":"2","author":"Sullivan","year":"2014","journal-title":"Cancer Metab."},{"key":"10.1016\/j.ymthe.2020.10.016_bib21","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1093\/carcin\/bgp157","article-title":"Benzyl isothiocyanate-mediated generation of reactive oxygen species causes cell cycle arrest and induces apoptosis via activation of MAPK in human pancreatic cancer cells","volume":"30","author":"Sahu","year":"2009","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ymthe.2020.10.016_bib22","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ccr.2006.08.009","article-title":"Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate","volume":"10","author":"Trachootham","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ymthe.2020.10.016_bib23","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/nm.4232","article-title":"Systemic depletion of L-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growth","volume":"23","author":"Cramer","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2020.10.016_bib24","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41698-019-0088-z","article-title":"Enzyme-mediated depletion of l-cyst(e)ine synergizes with thioredoxin reductase inhibition for suppression of pancreatic tumor growth","volume":"3","author":"Kshattry","year":"2019","journal-title":"NPJ Precis. Oncol."},{"key":"10.1016\/j.ymthe.2020.10.016_bib25","first-page":"L163","article-title":"Regulation of cellular glutathione","volume":"257","author":"Deneke","year":"1989","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ymthe.2020.10.016_bib26","first-page":"G7","article-title":"GSH transport in mitochondria: defense against TNF-induced oxidative stress and alcohol-induced defect","volume":"273","author":"Fern\u00e1ndez-Checa","year":"1997","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ymthe.2020.10.016_bib27","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrd2803","article-title":"Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?","volume":"8","author":"Trachootham","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2020.10.016_bib28","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1021\/bi00129a020","article-title":"A novel, sensitive, and specific assay for abasic sites, the most commonly produced DNA lesion","volume":"31","author":"Kubo","year":"1992","journal-title":"Biochemistry"},{"key":"10.1016\/j.ymthe.2020.10.016_bib29","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1006\/meth.2000.1057","article-title":"Detection of abasic sites and oxidative DNA base damage using an ELISA-like assay","volume":"22","author":"Kow","year":"2000","journal-title":"Methods"},{"key":"10.1016\/j.ymthe.2020.10.016_bib30","doi-asserted-by":"crossref","first-page":"5864","DOI":"10.1038\/sj.onc.1209874","article-title":"The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stability","volume":"25","author":"Gudmundsdottir","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.ymthe.2020.10.016_bib31","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/35077232","article-title":"Genome maintenance mechanisms for preventing cancer","volume":"411","author":"Hoeijmakers","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2020.10.016_bib32","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/nature06548","article-title":"Resistance to therapy caused by intragenic deletion in BRCA2","volume":"451","author":"Edwards","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2020.10.016_bib33","first-page":"5360","article-title":"Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas","volume":"56","author":"Goggins","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2020.10.016_bib34","first-page":"1417","article-title":"Evidence for the efficacy of Iniparib, a PARP-1 inhibitor, in BRCA2-associated pancreatic cancer","volume":"31","author":"Fogelman","year":"2011","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ymthe.2020.10.016_bib35","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1007\/s10495-008-0278-6","article-title":"In\u00a0vitro and in\u00a0vivo induction of apoptosis by capsaicin in pancreatic cancer cells is mediated through ROS generation and mitochondrial death pathway","volume":"13","author":"Zhang","year":"2008","journal-title":"Apoptosis"},{"key":"10.1016\/j.ymthe.2020.10.016_bib36","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1038\/sj.bjc.6605039","article-title":"Activation of ATM\/Chk1 by curcumin causes cell cycle arrest and apoptosis in human pancreatic cancer cells","volume":"100","author":"Sahu","year":"2009","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ymthe.2020.10.016_bib37","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ccell.2014.11.019","article-title":"Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progression","volume":"27","author":"Harris","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ymthe.2020.10.016_bib38","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/nature03443","article-title":"Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase","volume":"434","author":"Bryant","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2020.10.016_bib39","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nature03445","article-title":"Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy","volume":"434","author":"Farmer","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2020.10.016_bib40","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1200\/JCO.2014.60.0320","article-title":"Randomized, Double-Blind Phase II Trial With Prospective Classification by ATM Protein Level to Evaluate the Efficacy and Tolerability of Olaparib Plus Paclitaxel in Patients With Recurrent or Metastatic Gastric Cancer","volume":"33","author":"Bang","year":"2015","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ymthe.2020.10.016_bib41","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1056\/NEJMoa1506859","article-title":"DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer","volume":"373","author":"Mateo","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2020.10.016_bib42","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJMoa1903387","article-title":"Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer","volume":"381","author":"Golan","year":"2019","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2020.10.016_bib43","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2174\/1389450118666170711151518","article-title":"PARP Inhibitor Drugs in the Treatment of Breast, Ovarian, Prostate and Pancreatic Cancers: An Update of Clinical Trials","volume":"19","author":"Kamel","year":"2018","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.ymthe.2020.10.016_bib45","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1042\/bj3420249","article-title":"Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions","volume":"342","author":"D\u2019Amours","year":"1999","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymthe.2020.10.016_bib46","doi-asserted-by":"crossref","first-page":"39951","DOI":"10.1074\/jbc.M306592200","article-title":"Base excision repair intermediates induce p53-independent cytotoxic and genotoxic responses","volume":"278","author":"Sobol","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2020.10.016_bib47","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.mrfmmm.2010.12.016","article-title":"Role of oxidative stress and DNA damage in human carcinogenesis","volume":"711","author":"Kryston","year":"2011","journal-title":"Mutat. Res."},{"key":"10.1016\/j.ymthe.2020.10.016_bib48","doi-asserted-by":"crossref","first-page":"188","DOI":"10.2307\/3579174","article-title":"Clusters of DNA induced by ionizing radiation: formation of short DNA fragments. I. Theoretical modeling","volume":"145","author":"Holley","year":"1996","journal-title":"Radiat. Res."},{"key":"10.1016\/j.ymthe.2020.10.016_bib49","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/oxfordjournals.rpd.a006634","article-title":"Base excision repair processing of radiation-induced clustered DNA lesions","volume":"97","author":"Blaisdell","year":"2001","journal-title":"Radiat. Prot. Dosimetry"},{"key":"10.1016\/j.ymthe.2020.10.016_bib50","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2020.10.016_bib51","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature16965","article-title":"Genomic analyses identify molecular subtypes of pancreatic cancer","volume":"531","author":"Bailey","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2020.10.016_bib52","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature11547","article-title":"Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes","volume":"491","author":"Biankin","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2020.10.016_bib53","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature14169","article-title":"Whole genomes redefine the mutational landscape of pancreatic cancer","volume":"518","author":"Waddell","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2020.10.016_bib54","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S1471-4914(02)02434-6","article-title":"The relationship between the roles of BRCA genes in DNA repair and cancer predisposition","volume":"8","author":"Tutt","year":"2002","journal-title":"Trends Mol. Med."},{"issue":"Suppl 1","key":"10.1016\/j.ymthe.2020.10.016_bib55","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1038\/ejhg.2016.93","article-title":"The biological effects and clinical implications of BRCA mutations: where do we go from here?","volume":"24","author":"Stoppa-Lyonnet","year":"2016","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.ymthe.2020.10.016_bib56","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1200\/JCO.2014.56.2728","article-title":"Olaparib monotherapy in patients with advanced cancer and a germline BRCA1\/2 mutation","volume":"33","author":"Kaufman","year":"2015","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ymthe.2020.10.016_bib57","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1158\/1078-0432.CCR-13-0225","article-title":"Molecular pathways: how can BRCA-mutated tumors become resistant to PARP inhibitors?","volume":"20","author":"Bouwman","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2020.10.016_bib58","doi-asserted-by":"crossref","first-page":"5784","DOI":"10.1038\/sj.onc.1206678","article-title":"Roles of BRCA1 and BRCA2 in homologous recombination, DNA replication fidelity and the cellular response to ionizing radiation","volume":"22","author":"Powell","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.ymthe.2020.10.016_bib59","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1126\/science.aaw9872","article-title":"Cysteine depletion induces pancreatic tumor ferroptosis in mice","volume":"368","author":"Badgley","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2020.10.016_bib60","doi-asserted-by":"crossref","first-page":"5158","DOI":"10.1158\/0008-5472.CAN-17-0284","article-title":"Proinflammatory CXCL12-CXCR4\/CXCR7 Signaling Axis Drives Myc-Induced Prostate Cancer in Obese Mice","volume":"77","author":"Saha","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2020.10.016_bib61","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1038\/nprot.2006.339","article-title":"Clonogenic assay of cells in\u00a0vitro","volume":"1","author":"Franken","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ymthe.2020.10.016_bib62","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1093\/nar\/gkf467","article-title":"Clustered DNA damage induced by gamma radiation in human fibroblasts (HF19), hamster (V79-4) cells and plasmid DNA is revealed as Fpg and Nth sensitive sites","volume":"30","author":"Gulston","year":"2002","journal-title":"Nucleic Acids Res."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001620305505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001620305505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:00:32Z","timestamp":1761501632000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001620305505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S1525001620305505"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2020.10.016","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combinatorial Approaches to Enhance DNA Damage following Enzyme-Mediated Depletion of L-Cys for Treatment of Pancreatic Cancer","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2020.10.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}